Notices
Notice No20200925-10Notice Date25 Sep 2020
CategoryCompany relatedSegmentEquity
SubjectDiscontinuance of Buyback of the shares of Sun Pharmaceutical Industries Limited (Scrip code: 524715)
Content

 In continuation of the Exchange Notice No: 20200325-1 dated March 25, 2020, Trading Members are hereby informed that Sun Pharmaceutical Industries Limited (Scrip code: 524715) has now informed to the Exchange about discontinuation of the Buyback of its fully paid-up equity shares of face value of Re. 1/- each from the Open Market through the trading mechanism of the Exchange w.e.f. September 25, 2020.

 

Rupal Khandelwal

Senior Manager

Friday, September 25, 2020